EEC (Ectrodactyly, Ectodermal dysplasia, Clefting) syndrome: heterozygous mutation in the p63 gene (R279H) and DNA-based prenatal diagnosis

Br J Dermatol. 2002 Feb;146(2):216-20. doi: 10.1046/j.1365-2133.2002.04638.x.

Abstract

Background: Germline mis-sense mutations in the DNA-binding domain of the p63 gene have recently been established as the molecular basis for the autosomal dominant EEC (Ectrodactyly, Ectodermal dysplasia, Clefting) syndrome.

Objectives: To examine genomic DNA from a 36-year-old woman, her 58-year-old father and her 11-year-old son, all with the EEC syndrome, to determine the inherent p63 mutation and, after genetic counselling, to use knowledge of the mutation to undertake a first-trimester DNA-based prenatal diagnosis in a subsequent pregnancy.

Methods: Fetal DNA was extracted from chorionic villi and used to amplify exon 7 of p63 containing the potential mutation. Direct sequencing and restriction endonuclease digestion (loss of AciI site on mutant allele) were used for DNA-based prenatal diagnosis.

Results: We identified a heterozygous arginine to histidine p63 mutation, R279H, in all three affected individuals. Prenatal diagnosis demonstrated a homozygous wild-type sequence predicting an unaffected child: a healthy boy was subsequently born at full-term.

Conclusions: These data expand the p63 gene mutation database and provide the first example of a DNA-based prenatal test in this ectodermal dysplasia syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / genetics
  • Adult
  • Child
  • DNA Mutational Analysis
  • DNA-Binding Proteins
  • Ectodermal Dysplasia / genetics*
  • Female
  • Genes, Tumor Suppressor
  • Genetic Testing / methods
  • Germ-Line Mutation*
  • Humans
  • Male
  • Membrane Proteins*
  • Middle Aged
  • Mutation, Missense*
  • Pedigree
  • Phosphoproteins / genetics*
  • Prenatal Diagnosis / methods*
  • Syndrome
  • Toes / abnormalities
  • Trans-Activators / genetics*
  • Transcription Factors
  • Tumor Suppressor Proteins

Substances

  • CKAP4 protein, human
  • DNA-Binding Proteins
  • Membrane Proteins
  • Phosphoproteins
  • TP63 protein, human
  • Trans-Activators
  • Transcription Factors
  • Tumor Suppressor Proteins

Associated data

  • OMIM/604292